USP10 and neoplasm: Spautin‐1, as a potential USP10/13 antagonist, was reported to play an anti‐tumour effect in various cancers, such as chronic myeloid leukaemia, ovarian cancer and lung cancer.13 In this study, we investigated the role of spautin‐1 in malignant melanoma.